ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Russia approves second COVID-19 vaccine expresspharma
October 16, 2020The vaccine, developed by the Vector Institute in Siberia, completed early-stage human trials last month but the results have not been published yet and Phase III, trials have not yet begun.
Pharma Sources Insight January 2025
